EUVIMEDEUVIMED entdecken
Crossref

P21‐Activated Kinase 1 (PAK1) Modulates Therapeutic Response to Ionizing Radiation in Head and Neck Squamous Cell Carcinoma Cells

Swetha Rajendran, Rohan Prasad Surabhi, A Satheesh Kumar, Prarthana Gopinath, Vishnupriya Kanakaveti, Gouthaman Shanmugasundaram, M Michael Gromiha, Suresh Kumar Rayala, Ganesh Venkatraman iD

Molecular Carcinogenesis · 2025

DOI: 10.1002/mc.23902 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Carcinogenesis, 2025. Verfasst von Swetha Rajendran und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Genetics, Sri Ramachandra Faculty of Biomedical Sciences & Technology, Sri Ramachandra Institute of Higher Education and Research…. Hauptthemen laut MEDLINE: p21-Activated Kinases, Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Radiation Tolerance. Die Arbeit nennt 55 Literaturangaben. Gefördert von: This research was supported by the Board of Research in Nuclear Sciences (Grant No. 54/14/02/2020/35025)., Board of Research in Nuclear Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Head and neck squamous cell carcinoma (HNSCC) continues to be a formidable epithelial malignancy characterized by late‐stage detection and recurrence impacting survival. P21‐activated kinase‐1 (PAK1) was reported to be overexpressed in head and neck cancers and activated by ionizing radiation (IR), affecting treatment outcomes. Present investigations revealed that PAK1 silencing on HNSCC cells reverted the aggressive phenotype and showed impaired DNA damage repair upon IR exposure. Further HNSCC cells were resistant to IR up to 30 Gy with elevated pPAK1 levels. Radiation‐resistant (RR) HNSCC cells expressed radiation‐resistant markers, namely MRE‐11 and NME‐1; stemness markers—OCT4 and SOX2; and EMT & metastasis markers—vimentin, snail, and α‐smooth muscle actin (α‐SMA). In addition, HNSCC RR cells showed increased levels of DNA damage response protein H2AX, indicative of an aggressive phenotype with an augmented DNA repair machinery and a potential target for inhibition. Since H2AX appears to be a mechanistic hub for PAK1‐induced radiation resistance, using in silico methods, peptides were designed, and the PL‐8 peptide was chosen to target the phosphorylation of H2AX, which could enhance the sensitivity to IR and push the cells to radiation‐induced cell death. PL‐8 peptide inhibited H2AX phosphorylation on HNSCC cells and triggered radiation‐induced cell death as determined by functional assays. The present study reveals PAK1 induced in HNSCC cells by IR and causes resistance by enhancing DNA damage response mediated through γH2AX. To counteract this complex molecular interplay, we propose inhibiting γH2AX formation & silencing PAK1 appears to be a probable way forward in HNSCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

p21-Activated KinasesSquamous Cell Carcinoma of Head and NeckHead and Neck NeoplasmsRadiation ToleranceHumansRadiation, IonizingCell Line, TumorDNA RepairDNA DamageHistonesGene Expression Regulation, NeoplasticPhosphorylationCell Proliferation

Stichwörter der Autor:innen

HNSCCPAK1 knockoutcombinational therapyradiation resistanceγH2AX inhibition

Substanzen

p21-Activated KinasesPAK1 protein, humanHistonesH2AX protein, human

Autor:innen und Institutionen

  • Department of Human Genetics, Sri Ramachandra Faculty of Biomedical Sciences & Technology, Sri Ramachandra Institute of Higher Education and Research, Porur, Chennai, Tamil Nadu, India.
  • Department of Biotechnology, Indian Institute of Technology Madras, Guindy, Chennai, Tamil Nadu, India.
  • Division of Oncology, Departments of Medicine and Pathology, Stanford University School of Medicine, Stanford, California, USA.
  • Department of Surgical Oncology, Apollo Speciality Hospitals, Vanagaram, Chennai, Tamil Nadu, India.
  • Department of Bio-Medical Sciences, School of Bio Sciences & Technology, Vellore Institute of Technology Vellore, Vellore, Tamil Nadu, India.

ORCID-Profile: Ganesh Venkatraman

Förderung

  • This research was supported by the Board of Research in Nuclear Sciences (Grant No. 54/14/02/2020/35025).
  • Board of Research in Nuclear Sciences

Zitieren

APA

Rajendran, S., Surabhi, R. P., Kumar, A. S., Gopinath, P., Kanakaveti, V., Shanmugasundaram, G., Michael Gromiha, M., Rayala, S. K., & Venkatraman, G. (2025). P21‐Activated Kinase 1 (PAK1) Modulates Therapeutic Response to Ionizing Radiation in Head and Neck Squamous Cell Carcinoma Cells. Molecular Carcinogenesis. https://doi.org/10.1002/mc.23902

Vancouver

Rajendran S, Surabhi RP, Kumar AS, Gopinath P, Kanakaveti V, Shanmugasundaram G, et al. P21‐Activated Kinase 1 (PAK1) Modulates Therapeutic Response to Ionizing Radiation in Head and Neck Squamous Cell Carcinoma Cells. Molecular Carcinogenesis. 2025. doi:10.1002/mc.23902

BibTeX
@article{Rajendran2025,
  author = {Rajendran, Swetha and Surabhi, Rohan Prasad and Kumar, A Satheesh and Gopinath, Prarthana and Kanakaveti, Vishnupriya and Shanmugasundaram, Gouthaman and Michael Gromiha, M and Rayala, Suresh Kumar and Venkatraman, Ganesh},
  title = {P21‐Activated Kinase 1 (PAK1) Modulates Therapeutic Response to Ionizing Radiation in Head and Neck Squamous Cell Carcinoma Cells},
  journal = {Molecular Carcinogenesis},
  year = {2025},
  doi = {10.1002/mc.23902}
}
Kostenlos starten →